Physician profile
Anna Neumann
NPI 1346056025
$947.08
in general payments reported to CMS, 2019-2025
18 companies · $947 in 2025
The $947 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $947.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $947.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $947.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $198.63 | 2025 | Airsupra, Farxiga |
| Boston Scientific Corporation | $125.65 | 2025 | Wavewriter Alpha Prime 16, Watchman Flx |
| Janssen Pharmaceuticals, INC | $93.32 | 2025 | Spravato |
| Lilly USA, LLC | $76.67 | 2025 | Zepbound, Mounjaro |
| Novo Nordisk INC | $63.28 | 2025 | Wegovy, Ozempic, Rybelsus |
| Exact Sciences Corporation | $51.83 | 2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $49.98 | 2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Gilead Sciences, INC. | $46.78 | 2025 | Yeztugo |
| Kowa Pharmaceuticals America, INC. | $31.96 | 2025 | Zoryve |
| Merck Sharp & Dohme LLC | $30.89 | 2025 | Gardasil 9, M-M-R II, Capvaxive |
| Si-Bone, INC. | $28.15 | 2025 | |
| Pfizer INC. | $27.99 | 2025 | |
| Abbvie INC. | $23.50 | 2025 | |
| Inspire Medical Systems, INC. | $22.15 | 2025 | Inspire |
| Teva Pharmaceuticals USA, INC. | $21.52 | 2025 | Austedo Xr |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $19.65 | 2025 | Sublocade |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.70 | 2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $16.43 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Neumann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.